{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T19:03:20Z","timestamp":1772823800391,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T00:00:00Z","timestamp":1731196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374138"],"award-info":[{"award-number":["82374138"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s13318-024-00923-2","type":"journal-article","created":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T12:50:17Z","timestamp":1731243017000},"page":"39-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hypertensive Nephropathy Changes the Expression of Drug-Metabolizing Enzymes and Transporters in Spontaneously Hypertensive Rat Liver and Kidney"],"prefix":"10.1007","volume":"50","author":[{"given":"Yueqing","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minlong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Gan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,10]]},"reference":[{"issue":"5","key":"923_CR1","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41440-024-01622-w","volume":"47","author":"K Kario","year":"2024","unstructured":"Kario K, et al. The WHO Global Report 2023 on hypertension warning the emerging hypertension burden in globe and its treatment strategy. Hypertens Res. 2024;47(5):1099\u2013102.","journal-title":"Hypertens Res"},{"issue":"3","key":"923_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.4103\/hm.hm_16_22","volume":"6","author":"L Lin","year":"2022","unstructured":"Lin L, et al. Expert consensus on diagnosis and treatment of adult mental stress-induced hypertension in China (2022 revision): part B. Heart Mind. 2022;6(3):101\u20134.","journal-title":"Heart Mind"},{"issue":"6","key":"923_CR3","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.kint.2020.09.003","volume":"98","author":"C Yang","year":"2020","unstructured":"Yang C, et al. Executive summary for china kidney disease network (CK-NET) 2016 annual data report. Kidney Int. 2020;98(6):1419\u201323.","journal-title":"Kidney Int"},{"issue":"12","key":"923_CR4","first-page":"173","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang Y. Exploring the feasibility of a hypertension management model based on vascular function assessment using community population data analysis. Chin J Mod Drug Appl. 2018;12(12):173\u20134.","journal-title":"Chin J Mod Drug Appl"},{"issue":"33","key":"923_CR5","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","volume":"39","author":"B Williams","year":"2018","unstructured":"Williams B, et al. 2018 ESC\/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021\u2013104.","journal-title":"Eur Heart J"},{"key":"923_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.622862","volume":"11","author":"L Magro","year":"2020","unstructured":"Magro L, et al. Identifying and characterizing serious adverse drug reactions associated with drug-drug interactions in a spontaneous reporting database. Front Pharmacol. 2020;11: 622862.","journal-title":"Front Pharmacol"},{"issue":"8","key":"923_CR7","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1002\/jcph.1104","volume":"58","author":"S Yamazaki","year":"2018","unstructured":"Yamazaki S. Relationships of changes in pharmacokinetic parameters of substrate drugs in drug-drug interactions on metabolizing enzymes and transporters. J Clin Pharmacol. 2018;58(8):1053\u201360.","journal-title":"J Clin Pharmacol"},{"key":"923_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ejim.2019.05.002","volume":"65","author":"P Gallo","year":"2019","unstructured":"Gallo P, et al. Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients. Eur J Intern Med. 2019;65:51\u20137.","journal-title":"Eur J Intern Med"},{"issue":"6","key":"923_CR9","doi-asserted-by":"publisher","first-page":"403","DOI":"10.2174\/1389200221666200620210522","volume":"21","author":"S Sudsakorn","year":"2020","unstructured":"Sudsakorn S, et al. 2020 FDA drug-drug interaction guidance: a comparison analysis and action plan by pharmaceutical industrial scientists. Curr Drug Metab. 2020;21(6):403\u201326.","journal-title":"Curr Drug Metab"},{"key":"923_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev.pharmtox.39.1.1","volume":"39","author":"FP Guengerich","year":"1999","unstructured":"Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annu Rev Pharmacol Toxicol. 1999;39:1\u201317.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"923_CR11","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","volume":"58","author":"SK Nigam","year":"2018","unstructured":"Nigam SK. The SLC22 transporter family: a paradigm for the impact of drug transporters on metabolic pathways, signaling, and disease. Annu Rev Pharmacol Toxicol. 2018;58:663\u201387.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"3","key":"923_CR12","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.3748\/wjg.v22.i3.1260","volume":"22","author":"P Palatini","year":"2016","unstructured":"Palatini P, De Martin S. Pharmacokinetic drug interactions in liver disease: An update. World J Gastroenterol. 2016;22(3):1260\u201378.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"923_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.2174\/1389200221666200512113731","volume":"21","author":"Y Dong","year":"2020","unstructured":"Dong Y, et al. Changes of transporters and drug-metabolizing enzymes in nephrotic syndrome. Curr Drug Metab. 2020;21(5):368\u201378.","journal-title":"Curr Drug Metab"},{"issue":"6","key":"923_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s13659-018-0187-5","volume":"8","author":"XY Lu","year":"2018","unstructured":"Lu XY, et al. Codonopsis tangshen Oliv. amelioration effect on diabetic kidney disease rats induced by high fat diet feeding combined with streptozotocin. Nat Prod Bioprospect. 2018;8(6):441\u201351.","journal-title":"Nat Prod Bioprospect"},{"key":"923_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.746208","volume":"12","author":"W Zou","year":"2021","unstructured":"Zou W, et al. Drug transporters in the kidney: perspectives on species differences, disease status, and molecular docking. Front Pharmacol. 2021;12: 746208.","journal-title":"Front Pharmacol"},{"issue":"3","key":"923_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1161\/01.RES.48.3.309","volume":"48","author":"N Trippodo","year":"1981","unstructured":"Trippodo N, Frohlich E. Similarities of genetic (spontaneous) hypertension. Man and rat. Circ Res. 1981;48(3):309\u201319.","journal-title":"Circ Res"},{"key":"923_CR17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-1-4939-1050-2_3","volume":"1180","author":"AT Feldman","year":"2014","unstructured":"Feldman AT, Wolfe D. Tissue processing and hematoxylin and eosin staining. Methods Mol Biol. 2014;1180:31\u201343.","journal-title":"Methods Mol Biol"},{"issue":"1","key":"923_CR18","doi-asserted-by":"publisher","first-page":"22023","DOI":"10.1038\/s41598-020-79146-9","volume":"10","author":"E Manabe","year":"2020","unstructured":"Manabe E, et al. Reduced lifespan of erythrocytes in Dahl\/Salt sensitive rats is the cause of the renal proximal tubule damage. Sci Rep. 2020;10(1):22023.","journal-title":"Sci Rep"},{"issue":"2","key":"923_CR19","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.3892\/mmr.2014.2791","volume":"11","author":"J Zhu","year":"2015","unstructured":"Zhu J, Zhang Y, Yang C. Protective effect of 3-n-butylphthalide against hypertensive nephropathy in spontaneously hypertensive rats. Mol Med Rep. 2015;11(2):1448\u201354.","journal-title":"Mol Med Rep"},{"issue":"23","key":"923_CR20","doi-asserted-by":"publisher","first-page":"7690","DOI":"10.3390\/molecules28237690","volume":"28","author":"J Wang","year":"2023","unstructured":"Wang J, et al. Asperulosidic acid ameliorates renal interstitial fibrosis via removing indoxyl sulfate by up-regulating organic anion transporters in a unilateral ureteral obstruction mice model. Molecules. 2023;28(23):7690.","journal-title":"Molecules"},{"key":"923_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/B978-0-12-385118-5.00006-2","volume":"500","author":"J Jozefczuk","year":"2011","unstructured":"Jozefczuk J, Adjaye J. Quantitative real-time PCR-based analysis of gene expression. Methods Enzymol. 2011;500:99\u2013109.","journal-title":"Methods Enzymol"},{"issue":"4","key":"923_CR22","doi-asserted-by":"publisher","first-page":"332","DOI":"10.3109\/10641963.2014.972560","volume":"37","author":"G Zhentao","year":"2015","unstructured":"Zhentao G, et al. Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats. Clin Exp Hypertens. 2015;37(4):332\u20139.","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"923_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0264136","volume":"17","author":"AA Gutsol","year":"2022","unstructured":"Gutsol AA, et al. Comparative analysis of hypertensive nephrosclerosis in animal models of hypertension and its relevance to human pathology. Glomerulopathy. PLoS ONE. 2022;17(2): e0264136.","journal-title":"PLoS ONE"},{"issue":"23","key":"923_CR24","doi-asserted-by":"publisher","first-page":"12808","DOI":"10.3390\/ijms222312808","volume":"22","author":"M Zhao","year":"2021","unstructured":"Zhao M, et al. Cytochrome P450 enzymes and drug metabolism in humans. Int J Mol Sci. 2021;22(23):12808.","journal-title":"Int J Mol Sci"},{"issue":"08","key":"923_CR25","first-page":"993","volume":"20","author":"S Liang","year":"2020","unstructured":"Liang S, Chen W, Tang K. Investigation and analysis on overdose using of amlodipine besylate tablets on 105 inpatients. Eval Anal Drug-Use Hosp China. 2020;20(08):993\u20135+1000.","journal-title":"Eval Anal Drug-Use Hosp China"},{"issue":"3","key":"923_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1080\/07853890310008224","volume":"35","author":"P Honkakoski","year":"2003","unstructured":"Honkakoski P, Sueyoshi T, Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann Med. 2003;35(3):172\u201382.","journal-title":"Ann Med"},{"key":"923_CR27","doi-asserted-by":"publisher","DOI":"10.11131\/2015\/101178","author":"C Prakash","year":"2015","unstructured":"Prakash C, et al. nuclear receptors in drug metabolism, drug response and drug interactions. Nucl Receptor Res. 2015. https:\/\/doi.org\/10.11131\/2015\/101178.","journal-title":"Nucl Receptor Res"},{"key":"923_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2022.154097","volume":"101","author":"L Zhang","year":"2022","unstructured":"Zhang L, et al. Panaxytriol upregulates CYP3A4 expression based on the interaction of PXR, CAR, HSP90\u03b1, and RXR\u03b1. Phytomedicine. 2022;101: 154097.","journal-title":"Phytomedicine"},{"issue":"4","key":"923_CR29","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.bbrc.2010.02.058","volume":"393","author":"MA Istrate","year":"2010","unstructured":"Istrate MA, et al. Regulation of CYP3A4 by pregnane X receptor: the role of nuclear receptors competing for response element binding. Biochem Biophys Res Commun. 2010;393(4):688\u201393.","journal-title":"Biochem Biophys Res Commun"},{"issue":"16","key":"923_CR30","first-page":"22","volume":"2","author":"J Ding","year":"2017","unstructured":"Ding J. Effect of valsartan and salvianolate on pressure and renal function in the treatment of hypertensive nephropathy. Clin Res Pract. 2017;2(16):22\u20133.","journal-title":"Clin Res Pract"},{"key":"923_CR31","unstructured":"Qin C, et al. Inhibition of Salvianolate on human liver microsomal cytochrome P450 system. In: Abstracts compilation of the 8th physiology conference in Central and Southern China, 2012. pp. 90\u201391."},{"issue":"05","key":"923_CR32","first-page":"473","volume":"34","author":"Y Wang","year":"2018","unstructured":"Wang Y, et al. Effects of diltiazem combined with irbesartan on left ventricular remodeling andmyocardial ischemia in patients with essential hypertension. J Clin Cardiol. 2018;34(05):473\u20137.","journal-title":"J Clin Cardiol"},{"issue":"3","key":"923_CR33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1124\/jpet.105.087072","volume":"314","author":"Y Chen","year":"2005","unstructured":"Chen Y, et al. The nuclear receptors constitutive androstane receptor and pregnane X receptor cross-talk with hepatic nuclear factor 4alpha to synergistically activate the human CYP2C9 promoter. J Pharmacol Exp Ther. 2005;314(3):1125\u201333.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"923_CR34","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1124\/mol.62.3.737","volume":"62","author":"SS Ferguson","year":"2002","unstructured":"Ferguson SS, et al. Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site. Mol Pharmacol. 2002;62(3):737\u201346.","journal-title":"Mol Pharmacol"},{"issue":"04","key":"923_CR35","first-page":"463","volume":"26","author":"H Li","year":"2020","unstructured":"Li H, et al. Renoprotective effect of diltiazem sustained-release capsule in patients with hypertensive nephropathy. South China J Cardiovasc Dis. 2020;26(04):463\u20136+488.","journal-title":"South China J Cardiovasc Dis"},{"issue":"23","key":"923_CR36","first-page":"1765","volume":"43","author":"A Wen","year":"2008","unstructured":"Wen A, Xu X. Research progress of organic anion transport peptide 1B1. Chin Pharm J. 2008;43(23):1765\u20139.","journal-title":"Chin Pharm J"},{"issue":"3","key":"923_CR37","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/ki.2013.399","volume":"85","author":"CK Yeung","year":"2014","unstructured":"Yeung CK, et al. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport. Kidney Int. 2014;85(3):522\u20138.","journal-title":"Kidney Int"},{"issue":"21","key":"923_CR38","first-page":"3318","volume":"15","author":"J Tang","year":"2020","unstructured":"Tang J, Wang L, Tian C. Study on the clinical efficacy of salvia miltiorrhiza polyphenolate for injection in the adjuvant treatment of hypertension patients. World Chin Med. 2020;15(21):3318\u201322.","journal-title":"World Chin Med"},{"issue":"3","key":"923_CR39","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1254\/fpj.117.177","volume":"117","author":"T Sekine","year":"2001","unstructured":"Sekine T. Molecular identification of the multispecific organic anion transporter family (the OAT family): the role in the pharmacokinetics and toxicokinetics. Nihon Yakurigaku Zasshi. 2001;117(3):177\u201386.","journal-title":"Nihon Yakurigaku Zasshi"},{"issue":"3","key":"923_CR40","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1124\/pr.111.004614","volume":"64","author":"A Emami Riedmaier","year":"2012","unstructured":"Emami Riedmaier A, et al. Organic anion transporters and their implications in pharmacotherapy. Pharmacol Rev. 2012;64(3):421\u201349.","journal-title":"Pharmacol Rev"},{"issue":"15","key":"923_CR41","first-page":"1838","volume":"44","author":"L Lei","year":"2023","unstructured":"Lei L, Dong Y, Wang X. Correlation analysis of serum PEPT1 and PEPT2 expression with renal dysfunction andprognosis in patients with hypertensive nephropathy. Int J Lab Med. 2023;44(15):1838\u201342+ 1847.","journal-title":"Int J Lab Med"},{"issue":"4","key":"923_CR42","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/03602532.2018.1554673","volume":"50","author":"D Xu","year":"2018","unstructured":"Xu D, et al. Regulation of brain drug metabolizing enzymes and transporters by nuclear receptors. Drug Metab Rev. 2018;50(4):407\u201314.","journal-title":"Drug Metab Rev"},{"issue":"2","key":"923_CR43","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1124\/jpet.102.035014","volume":"302","author":"PM Gerk","year":"2002","unstructured":"Gerk PM, Vore M. Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition. J Pharmacol Exp Ther. 2002;302(2):407\u201315.","journal-title":"J Pharmacol Exp Ther"},{"key":"923_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jep.2015.12.033","volume":"179","author":"H Chen","year":"2016","unstructured":"Chen H, et al. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2. J Ethnopharmacol. 2016;179:197\u2013207.","journal-title":"J Ethnopharmacol"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-024-00923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-024-00923-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-024-00923-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T07:31:29Z","timestamp":1738827089000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-024-00923-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,10]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["923"],"URL":"https:\/\/doi.org\/10.1007\/s13318-024-00923-2","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,10]]},"assertion":[{"value":"15 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest with the contents of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was funded by The National Natural Science Foundation of China, China, no. 82374138.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"All data supporting the findings of this study are available upon request by contacting the corresponding author.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"The study was approved by the Welfare and Ethical Committee for Experimental Animal Care of Southern Medical University on April 23, 2024, with approval number of SMUL202404023. And all institutional and national guidelines for the care of the laboratory animals were followed.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Yueqing Pan: Methodology, Investigation, Validation, Formal Analysis, Writing-Original Draft. Zhuan Yang: Methodology, Writing-Original Draft. Minlong Wei: Investigation, Validation. Yulin Gan: Grammar Modification. Menghua Liu: Conceptualization, Project Administration Supervision, Writing-Review & Editing. Wei Zou: Conceptualization, Supervision, Funding Acquisition.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author Contributions"}}]}}